University of Florida: Leukemia trials
The registry lists 10 Leukemia studies with University of Florida as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 4Phase 2 3Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete RemissionTerminatedNCT04914676Phase 2Results posted
- Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)TerminatedNCT02773732Phase 1/2Results posted
- Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual DiseaseTerminatedNCT02370888Phase 1Results posted
- Investigating Integrative Therapies for Symptom Management in Adults With Acute LeukemiaTerminatedNCT04185428Not applicable
- iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)WithdrawnNCT03207334Phase 2
- Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)TerminatedNCT03016130Phase 3
- Beat AML Core StudyCompletedNCT02927106
- iCare for Cancer PatientsTerminatedNCT02435550Not applicable
- Phase I, Dose Escalation Study of DecitabineCompletedNCT02264873Phase 1
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDSTerminatedNCT01085656Phase 1